As the patents on various weight-loss drugs near expiration, companies in India and China are vying to make lower-cost versions that will widen access to such treatments
such as Wegovy could soon become a lot cheaper — and reach more people — thanks to Chinese and Indian pharmaceutical companies. A long queue of companies is developing copies of the complex biological drugs, and some are racing to create modified or improved versions to compete in the global market.
Globally, one billion people have obesity or are overweight — and hundreds of millions of them live in India and China. Lei Qian, vice-president of clinical development at Innovent Biologics in Shanghai, China, says that “demand for anti-obesity drugs is very strong” in the country.of weight-loss drugs has taken the world by storm. They work by mimicking a naturally occurring hormone called glucagon-like peptide 1 .
Companies are also innovating in how they synthesize the drugs, fill the vials and manufacture the injection devices, says Zutshi, whose company is focusing on developing biosimilars for the global market.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tesla Cybertruck: Everything We Know About Pricing, Availability, Cheaper VersionsThe Tesla Cybertruck is on sale now in the U.S., but currently, it's only offered in high-end trims. When will the more affordable versions arrive?
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines. WHO said Thursday that it has fielded reports of fake semaglutide _ the active ingredient in Novo Nordisk’s Wegovy and Ozempic.
Read more »
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugsThe World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
Read more »
Don't Break The Bank: 29 Cheaper Alternatives To Popular Expensive ProductsThe only thing different about these products is the price tag. 👀
Read more »